BHR Pharmaceuticals Ltd began life in 1990. The first products were branded generics in the arthritis, infection and gastrointestinal fields. BHR took on Concise – a pregnancy test from Hybritech. A major product group, urine testing strips from Macherey Nagel in Germany, was then introduced to the UK market by BHR.

Since the launch of these two product groups in 1993-94, BHR has rapidly gained extensive knowledge and experience in the Point-of-Care (POC) sector in the UK health care industry. BHR has the ability to source the best products from around the world’s leading diagnostic companies.

BHR’s major strength is in the cardiovascular, female health and diabetes markets. BHR markets the CardioChek brand of blood chemistry analyser from PTS Inc in Indiana. This brand is now among the most widely used analyser for cholesterol and full lipid profiling in the UK. Health promotion teams have particularly embraced this system due to its accuracy, ease-of-use and cost/benefit ratio.

BHR markets its own brand of professional pregnancy tests – CHECK-MATE and along with this are the actimPARTUS and actimPROM tests (detect cervical ripeness and premature rupture of the membranes respectively), form the core of the tests in the female health segment.

BHR’s sales activities are conducted via both a direct sales force and a distributor / agent network, servicing a wide number of specific market segments in the UK and Ireland. BHR’s objectives are to offer the most economical, accurate and precise POC tests for both disease screening programmes as well as for therapeutic monitoring. These aims and values will enhance the quality of life of patients and at the same time, reduce costs to both the NHS and patients directly.